VisEn offers new fluorescence imaging options, enables multi-modal fusion
April 23, 2009
APRIL 23, 2009--During the just-concluded 100th Annual Meeting of the American Association of Cancer Research (AACR, April 18-22, Denver, CO), VisEn Medical Inc. (Bedford, MA), introduced its new FAST ("Fluorescent Activatible Sensor Technology") imaging agent platform for advanced imaging of key disease-associated biomarkers and drug response in vivo.
Sponsored Recommendations
Sponsored Recommendations
Optical Filter Orientation Guide
Sept. 5, 2024
Ensure Optimal Performance with Shortpass Filters
Sept. 5, 2024
Voice your opinion!
Voice your opinion!